BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34679199)

  • 21. Refining the ammonia hypothesis: a physiology-driven approach to the treatment of hepatic encephalopathy.
    Tapper EB; Jiang ZG; Patwardhan VR
    Mayo Clin Proc; 2015 May; 90(5):646-58. PubMed ID: 25865476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy.
    Jalan R; Wright G; Davies NA; Hodges SJ
    Med Hypotheses; 2007; 69(5):1064-9. PubMed ID: 17467190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic detoxification and hepatic function in chronic active hepatitis with and without cirrhosis.
    Müting D; Kalk JF; Fischer R; Wuzel H; Reikowski J
    Dig Dis Sci; 1988 Jan; 33(1):41-6. PubMed ID: 3123178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel aspects of glutamine synthetase in ammonia homeostasis.
    Zhou Y; Eid T; Hassel B; Danbolt NC
    Neurochem Int; 2020 Nov; 140():104809. PubMed ID: 32758585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Function of zinc in liver disease].
    Katayama K
    Nihon Rinsho; 2016 Jul; 74(7):1126-31. PubMed ID: 27455801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperammonemia Is Associated with Increasing Severity of Both Liver Cirrhosis and Hepatic Encephalopathy.
    Khan A; Ayub M; Khan WM
    Int J Hepatol; 2016; 2016():6741754. PubMed ID: 27847646
    [No Abstract]   [Full Text] [Related]  

  • 27. Current state of knowledge of hepatic encephalopathy (part I): newer treatment strategies for hyperammonemia in liver failure.
    Kristiansen RG
    Metab Brain Dis; 2016 Dec; 31(6):1357-1358. PubMed ID: 27651377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ammonia and glutamine metabolism in human liver slices: new aspects on the pathogenesis of hyperammonaemia in chronic liver disease.
    Kaiser S; Gerok W; Häussinger D
    Eur J Clin Invest; 1988 Oct; 18(5):535-42. PubMed ID: 3147907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interorgan ammonia metabolism in liver failure: the basis of current and future therapies.
    Wright G; Noiret L; Olde Damink SW; Jalan R
    Liver Int; 2011 Feb; 31(2):163-75. PubMed ID: 20673233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ammonia and autophagy: An emerging relationship with implications for disorders with hyperammonemia.
    Soria LR; Brunetti-Pierri N
    J Inherit Metab Dis; 2019 Nov; 42(6):1097-1104. PubMed ID: 30671986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of hepatic encephalopathy in patients with cirrhosis.
    Wright G; Jalan R
    Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of Carnitine Supplementation for the Complications of Liver Cirrhosis.
    Hanai T; Shiraki M; Imai K; Suetugu A; Takai K; Shimizu M
    Nutrients; 2020 Jun; 12(7):. PubMed ID: 32610446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ammonia: A novel target for the treatment of non-alcoholic steatohepatitis.
    Thomsen KL; De Chiara F; Rombouts K; Vilstrup H; Andreola F; Mookerjee RP; Jalan R
    Med Hypotheses; 2018 Apr; 113():91-97. PubMed ID: 29523305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pivotal role of glutamine synthetase in ammonia detoxification.
    Hakvoort TB; He Y; Kulik W; Vermeulen JL; Duijst S; Ruijter JM; Runge JH; Deutz NE; Koehler SE; Lamers WH
    Hepatology; 2017 Jan; 65(1):281-293. PubMed ID: 27641632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BabaoDan cures hepatic encephalopathy by decreasing ammonia levels and alleviating inflammation in rats.
    Lu L; Wu C; Lu BJ; Xie D; Wang Z; Bahaji Azami NL; An YT; Wang HJ; Ye G; Sun MY
    J Ethnopharmacol; 2020 Mar; 249():112301. PubMed ID: 31622746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ammonia-lowering strategies for the treatment of hepatic encephalopathy.
    Rose CF
    Clin Pharmacol Ther; 2012 Sep; 92(3):321-31. PubMed ID: 22871998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. α-Ketoglutaramate: an overlooked metabolite of glutamine and a biomarker for hepatic encephalopathy and inborn errors of the urea cycle.
    Cooper AJ; Kuhara T
    Metab Brain Dis; 2014 Dec; 29(4):991-1006. PubMed ID: 24234505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-Ornithine L-Aspartate for the Treatment of Sarcopenia in Chronic Liver Disease: The Taming of a Vicious Cycle.
    Butterworth RF
    Can J Gastroenterol Hepatol; 2019; 2019():8182195. PubMed ID: 31183339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral cortex ammonia and glutamine metabolism during liver insufficiency-induced hyperammonemia in the rat.
    Dejong CH; Kampman MT; Deutz NE; Soeters PB
    J Neurochem; 1992 Sep; 59(3):1071-9. PubMed ID: 1494899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral effects of ammonia in liver disease: current hypotheses.
    Ott P; Vilstrup H
    Metab Brain Dis; 2014 Dec; 29(4):901-11. PubMed ID: 24488230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.